2.Stress-Induced Cardiomyopathy Presenting as Acute Myocardial Infarction.
Sun Young LEE ; Choon Young LEE ; Hyun Joong KIM ; Ho Hyun LEE ; Hyeon Cheol GWON ; Duk Kyung KIM
Yonsei Medical Journal 2002;43(5):670-674
Stress-induced cardiomyopathy is described as an acute cardiomyopathy that occurs under the influence of an excessive level of catecholamine related to intense emotional stress. A 64-year-old woman presented with symptoms of acute myocardial infarction after emotional upset, but her coronary angiographic findings were revealed to be normal. Diffuse T wave inversions were observed in her electrocardiograms with akinetic wall motions sparing the basal segments in her left ventriculography. After four months, her electrocardiogram and echocardiogram findings had completely returned to normal. The precise diagnosis of this acute cardiomyopathy must be emphasized because it can initially be misdiagnosed as acute coronary syndromes. However in complete contrast to acute myocardial infarction, it has a rapid and favorable recovery with hardly any sequelae after a few months.
Case Report
;
Electrocardiography
;
Female
;
Human
;
Middle Age
;
Myocardial Diseases/*complications
;
Myocardial Infarction/*etiology
;
Stress, Psychological/*complications
5.The damage of cardiovascular system in heroin abuses.
Xiao-shan LIU ; Yu-chuang CHEN ; Zhao-hui LI ; Xiangying SITU ; Haiying CHENG
Journal of Forensic Medicine 2004;20(4):247-249
The heroin abuses can seriously damage human body system, among them the damage of cardiovascular system is various. In this paper those damages involved heart rate, blood pressure, electrocardiogram, heart function, blood circulation, the changes of some material inside, and complications of cardiovascular system are reviewed.
Arrhythmias, Cardiac/etiology*
;
Blood Circulation
;
Blood Pressure
;
Cardiovascular Diseases/physiopathology*
;
Death, Sudden/etiology*
;
Electrocardiography
;
Heart Rate
;
Heroin Dependence/physiopathology*
;
Humans
;
Myocardial Ischemia/etiology*
6.Sulfur dioxide acts as a novel endogenous gaseous signaling molecule in the cardiovascular system.
Shan-Shan CHEN ; Chao-Shu TANG ; Hong-Fang JIN ; Jun-Bao DU
Chinese Medical Journal 2011;124(12):1901-1905
OBJECTIVESulfur dioxide was considered to be toxic and detrimental to human health. However, this review highlights recent advances that suggest sulfur dioxide might be a novel endogenous gaseous signaling molecule involved in the regulation of cardiovascular functions.
DATA SOURCESThe data used in this review were mainly from the studies reported in Medline and PubMed published from 1986 to 2010.
STUDY SELECTIONOriginal articles and critical reviews selected were relevant to exogenous and endogenous sulfur dioxide.
RESULTSThe sulfur dioxide/aspartate amino transferase pathway is endogenously generated in the cardiovascular system, and sulfur dioxide shows broad bioactive effects, such as antihypertension, vasodilation, and amelioration of vascular remodeling. A disturbed sulfur dioxide/aspartate amino transferase pathway is known to be involved in the pathogenesis of many cardiovascular diseases, such as ischemia-reperfusion injury, monocrotaline-induced pulmonary hypertension, athrosclerosis, spontaneous hypertension and hypoxic pulmonary hypertension. Furthermore, in experimental studies the prognosis of these cardiovascular diseases can be improved by targeting endogenous sulfur dioxide.
CONCLUSIONThe findings suggest that sulfur dioxide is a novel endogenous gaseous signaling molecule involved in the regulation of cardiovascular functions.
Animals ; Cardiovascular Diseases ; etiology ; Humans ; Hypertension, Pulmonary ; etiology ; Myocardial Reperfusion Injury ; etiology ; Rats ; Rats, Inbred SHR ; Signal Transduction ; physiology ; Sulfur Dioxide ; metabolism
7.Development and validation of ischemic heart disease and stroke prognostic models using large-scale real-world data from Japan.
Shigeto YOSHIDA ; Shu TANAKA ; Masafumi OKADA ; Takuya OHKI ; Kazumasa YAMAGISHI ; Yasushi OKUNO
Environmental Health and Preventive Medicine 2023;28():16-16
BACKGROUND:
Previous cardiovascular risk prediction models in Japan have utilized prospective cohort studies with concise data. As the health information including health check-up records and administrative claims becomes digitalized and publicly available, application of large datasets based on such real-world data can achieve prediction accuracy and support social implementation of cardiovascular disease risk prediction models in preventive and clinical practice. In this study, classical regression and machine learning methods were explored to develop ischemic heart disease (IHD) and stroke prognostic models using real-world data.
METHODS:
IQVIA Japan Claims Database was searched to include 691,160 individuals (predominantly corporate employees and their families working in secondary and tertiary industries) with at least one annual health check-up record during the identification period (April 2013-December 2018). The primary outcome of the study was the first recorded IHD or stroke event. Predictors were annual health check-up records at the index year-month, comprising demographic characteristics, laboratory tests, and questionnaire features. Four prediction models (Cox, Elnet-Cox, XGBoost, and Ensemble) were assessed in the present study to develop a cardiovascular disease risk prediction model for Japan.
RESULTS:
The analysis cohort consisted of 572,971 invididuals. All prediction models showed similarly good performance. The Harrell's C-index was close to 0.9 for all IHD models, and above 0.7 for stroke models. In IHD models, age, sex, high-density lipoprotein, low-density lipoprotein, cholesterol, and systolic blood pressure had higher importance, while in stroke models systolic blood pressure and age had higher importance.
CONCLUSION
Our study analyzed classical regression and machine learning algorithms to develop cardiovascular disease risk prediction models for IHD and stroke in Japan that can be applied to practical use in a large population with predictive accuracy.
Humans
;
Cardiovascular Diseases/epidemiology*
;
Prognosis
;
Prospective Studies
;
Japan/epidemiology*
;
Stroke/etiology*
;
Myocardial Ischemia/epidemiology*
;
Risk Assessment/methods*
8.Report on Cardiovascular Health and Diseases in China 2021: An Updated Summary.
Biomedical and Environmental Sciences 2022;35(7):573-603
In 2019, cardiovascular disease (CVD) accounted for 46.74% and 44.26% of all deaths in rural and urban areas, respectively. Two out of every five deaths were due to CVD. It is estimated that about 330 million patients suffer from CVD in China. The number of patients suffering from stroke, coronary heart disease, heart failure, pulmonary heart disease, atrial fibrillation, rheumatic heart disease, congenital heart disease, lower extremity artery disease and hypertension are 13.00 million, 11.39 million, 8.90 million, 5.00 million, 4.87 million, 2.50 million, 2.00 million, 45.30 million, and 245.00 million, respectively. Given that China is challenged by the dual pressures of population aging and steady rise in the prevalence of metabolic risk factors, the burden caused by CVD will continue to increase, which has set new requirements for CVD prevention and treatment and the allocation of medical resources in China. It is important to reduce the prevalence through primary prevention, increase the allocation of medical resources for CVD emergency and critical care, and provide rehabilitation services and secondary prevention to reduce the risk of recurrence, re-hospitalization and disability in CVD survivors. The number of people suffering from hypertension, dyslipidemia and diabetes in China has reached hundreds of millions. Since blood pressure, blood lipids, and blood glucose levels rise mostly insidiously, vascular disease or even serious events such as myocardial infarction and stroke often already occured at the time of detection in this population. Hence, more strategies and tasks should be taken to prevent risk factors such as hypertension, dyslipidemia, diabetes, obesity, and smoking, and more efforts should be made in the assessment of cardiovascular health status and the prevention, treatment, and research of early pathological changes.
Cardiovascular Diseases/etiology*
;
China/epidemiology*
;
Diabetes Mellitus
;
Dyslipidemias
;
Humans
;
Hypertension/epidemiology*
;
Myocardial Infarction
;
Risk Factors
;
Stroke/epidemiology*
9.Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction.
Dong Goo KANG ; Myung Ho JEONG ; Yongkeun AHN ; Shung Chull CHAE ; Seung Ho HUR ; Taek Jong HONG ; Young Jo KIM ; In Whan SEONG ; Jei Keon CHAE ; Jay Young RHEW ; In Ho CHAE ; Myeong Chan CHO ; Jang Ho BAE ; Seung Woon RHA ; Chong Jin KIM ; Yang Soo JANG ; Junghan YOON ; Ki Bae SEUNG ; Seung Jung PARK
Journal of Korean Medical Science 2009;24(5):800-806
The incidence of ischemic heart disease has been increased rapidly in Korea. However, the clinical effects of antecedent hypertension on acute myocardial infarction have not been identified. We assessed the relationship between antecedent hypertension and clinical outcomes in 7,784 patients with acute myocardial infarction in the Korea Acute Myocardial Infarction Registry during one-year follow-up. Diabetes mellitus, hyperlipidemia, cerebrovascular disease, heart failure, and peripheral artery disease were more prevalent in hypertensives (n=3,775) than nonhypertensives (n=4,009). During hospitalization, hypertensive patients suffered from acute renal failure, shock, and cerebrovascular event more frequently than in nonhypertensives. During follow-up of one-year, the incidence of major adverse cardiac events was higher in hypertensives. In multi-variate adjustment, old age, Killip class > or =III, left ventricular ejection fraction <45%, systolic blood pressure <90 mmHg on admission, post procedural TIMI flow grade < or =2, female sex, and history of hypertension were independent predictors for in-hospital mortality. However antecedent hypertension was not significantly associated with one-year mortality. Hypertension at the time of acute myocardial infarction is associated with an increased rate of in-hospital mortality.
Acute Disease
;
Age Factors
;
Aged
;
Cerebrovascular Disorders/etiology
;
Diabetes Mellitus/etiology
;
Female
;
Heart Failure/etiology
;
Hospital Mortality
;
Humans
;
Hyperlipidemias/etiology
;
Hypertension/*complications
;
Male
;
Middle Aged
;
Myocardial Infarction/complications/*mortality/therapy
;
Peripheral Vascular Diseases/etiology
;
Predictive Value of Tests
;
Registries
;
Sex Factors
10.Energy metabolism disorder and myocardial injury in chronic myocardial ischemia with Qi deficiency and blood stasis syndrome based on 2-DE proteomics.
Yong WANG ; Wen-Jing CHUO ; Chun LI ; Shu-Zhen GUO ; Jian-Xin CHEN ; Jun-da YU ; Wei WANG
Chinese journal of integrative medicine 2013;19(8):616-620
OBJECTIVETo inquire the characteristic proteins in chronic myocardial ischemia by testing twodimensional electrophoresis (2-DE) map to explore the possible inherent pathological mechanism and the therapeutic intervention of qi deficiency and blood stasis syndrome.
METHODSAmeroid constrictor ring was placed on the first interval of left anterior descending coronary artery to prepare chronic myocardial ischemia model on Chinese miniature swine. Animals were randomly divided into sham group and model group with 10 animals in each group, respectively. The dynamic symptoms observation of the four diagnostic information was collected from 0 to 12 weeks. Echocardiography was employed to evaluate cardiac function and the degree of myocardial ischemia, 2-DE and matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF-MS) were used to carry out proteomics research on animals. Enzyme-linked immunosorbent assay was applied to identify the relevant differential proteins on chronic myocardial ischemia with qi deficiency and blood stasis syndrome.
RESULTSThe preliminary study found that at the 12th week, chronic myocardial ischemia with qi deficiency and blood stasis syndrome model was established stably. Compared with the sham group, there were 8 different proteins down-regulated, 22 proteins up-regulated significantly. After validated by MALDITOF-MS/MS, 11 protein spots were identified. Distinct proteins were mainly associated with energy metabolism and myocardial structural injury, including isocitrate dehydrogenase 3 (NAD+) alpha, NADH dehydrogenase (NAD) Fe-S protein 1, chain A (crystal structure of aldose reductase by binding domain reveals a new Nadph), heat shock protein 27 (HSP27), oxidoreductase (NAD-binding protein), antioxidant protein isoform, cardiac troponin T (cTnT), myosin (myosin light polypeptide), cardiac alpha tropomyosin, apolipoprotein A-I and albumin.
CONCLUSIONDown-regulated energy metabolism disorder mediated by NADH respiratory chain and myocardial injury may be the pathogenesis of myocardial ischemia with qi deficiency and blood stasis syndrome. These proteins may be the potential diagnostic marker(s) for qi deficiency and blood stasis syndrome, finally provided new clues for new therapeutic drug target of Chinese medicine.
Animals ; Blood Coagulation Disorders ; complications ; metabolism ; Electrophoresis, Gel, Two-Dimensional ; Energy Metabolism ; physiology ; Metabolic Diseases ; etiology ; metabolism ; Myocardial Ischemia ; complications ; metabolism ; Myocardial Reperfusion Injury ; etiology ; metabolism ; Proteomics ; methods ; Qi ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization ; Swine ; Swine, Miniature ; Syndrome